Old Ayala Inc Quick Ratio (AYLA) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Old Ayala Inc   (AYLA)

Old Ayala Inc 's Quick Ratio

AYLA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 0.32 a new company low.

Within Biotechnology & Pharmaceuticals industry 182 other companies have achieved higher Quick Ratio than Old Ayala Inc in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 1556 to 3575.

Explain Quick Ratio?
How much Cash & cash equivalents AYLA´s has?
What are AYLA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AYLA/financial-strength
https://api.csimarket.com/api/v1/companies/AYLA/fundamentals
https://api.csimarket.com/api/v1/companies/AYLA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
AYLA Quick Ratio (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4
Y / Y Current Liabilities Change -19.68 %
Y / Y Cash & cash equivalent Change -93.49 %
Quick Ratio MRQ 0.32
AYLA's Total Ranking # 3575
Seq. Current Liabilities Change 32.09 %
Seq. Cash & cash equivalent Change -78.49 %



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 183
Healthcare Sector # 1042
Overall Market # 3575


Quick Ratio Statistics
High Average Low
9.91 5.61 0.32
(Jun 30 2020)   (Dec 31 2022)




Financial Statements
Old Ayala Inc 's Current Liabilities $ 8 Millions Visit AYLA's Balance sheet
Old Ayala Inc 's Cash & cash equivalent $ 2 Millions Visit AYLA's Balance sheet
Source of AYLA's Sales Visit AYLA's Sales by Geography


Cumulative Old Ayala Inc 's Quick Ratio

AYLA's Quick Ratio for the trailling 12 Months

AYLA Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months 		(Jun 30 2022)
12 Months 		(Mar 31 2022)
12 Months 		(Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -12.67 %
Y / Y Cash & cash equivalent TTM Growth -65.94 %
Quick Ratio TTM 2.44
Total Ranking TTM # 4606
Seq. Current Liabilities TTM Growth -6.92 %
Seq. Cash & cash equivalent TTM Growth -36.28 %

Quick ratio ranking by company, industry and sector >> Back to AYLA Financial Strength Comparisons >> Go to Compare AYLA Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in AYLA's Current Liabilities to $7.54 millions, cumulative Quick Ratio to 2.44 below the AYLA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 189 other companies have achieved higher Quick Ratio than Old Ayala Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4492 to 4606.

Explain Quick Ratio?
How much Cash & cash equivalents AYLA´s has?
What are AYLA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 190
Healthcare Sector # 1171
Within the Market # 4606


trailing twelve months Quick Ratio Statistics
High Average Low
8.38 6.26 2.44
(Mar 31 2021)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Biotechnology & Pharmaceuticals Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Valneva Se  0.88 $ 306.532  Millions$ 349.091  Millions
Eloxx Pharmaceuticals Inc   0.83 $ 19.207  Millions$ 23.091  Millions
Gilead Sciences Inc   0.82 $ 6,385.000  Millions$ 7,758.000  Millions
Redwoods Acquisition Corp  0.67 $ 0.341  Millions$ 0.506  Millions
Ladrx Corporation  0.63 $ 1.375  Millions$ 2.188  Millions
Tc Biopharm holdings Plc  0.63 $ 13.333  Millions$ 21.331  Millions
Elutia Inc   0.60 $ 16.989  Millions$ 28.246  Millions
Amgen Inc   0.59 $ 9,305.000  Millions$ 15,687.000  Millions
C4 Therapeutics Inc   0.58 $ 29.754  Millions$ 51.377  Millions
Aceragen Inc   0.56 $ 12.044  Millions$ 21.423  Millions
Champions Oncology Inc   0.56 $ 11.645  Millions$ 20.797  Millions
Novavax inc   0.54 $ 1,336.883  Millions$ 2,459.944  Millions
Apeiron Capital Investment Corp   0.51 $ 1.094  Millions$ 2.136  Millions
Mesoblast Limited  0.47 $ 67.619  Millions$ 143.767  Millions
Biogen Inc   0.45 $ 1,473.500  Millions$ 3,272.800  Millions
Cyclo Therapeutics Inc   0.44 $ 1.543  Millions$ 3.481  Millions
Protalix Biotherapeutics inc   0.43 $ 17.111  Millions$ 39.907  Millions
Zeo Scientifix Inc   0.42 $ 1.423  Millions$ 3.426  Millions
Tevogen Bio Holdings Inc   0.37 $ 0.129  Millions$ 0.351  Millions
Futuretech Ii Acquisition Corp   0.33 $ 0.263  Millions$ 0.788  Millions
Old Ayala Inc   0.32 $ 2.408  Millions$ 7.536  Millions
Brainstorm Cell Therapeutics inc   0.30 $ 2.983  Millions$ 9.781  Millions
Immunitybio inc   0.21 $ 107.184  Millions$ 500.861  Millions
Intensity Therapeutics Inc   0.20 $ 1.312  Millions$ 6.675  Millions
Enzo Biochem Inc  0.16 $ 5.054  Millions$ 32.201  Millions
Sorrento Therapeutics Inc   0.16 $ 49.978  Millions$ 319.738  Millions
Replicel Life Sciences Inc   0.15 $ 0.341  Millions$ 2.348  Millions
Zura Bio Limited  0.12 $ 1.567  Millions$ 12.865  Millions
Alvotech  0.08 $ 66.427  Millions$ 813.758  Millions
Mosaic Immunoengineering Inc   0.07 $ 0.221  Millions$ 3.164  Millions

Date modified: 2026-09-08T15:10:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.